The Investor Relations website contains ... NASDAQ | FLGT (Common Stock). $20.27. Change. +0.18 ... Fulgent Reports Fourth Quarter and Full Year 2023 Financial ...
People also ask
Is FLGT a good stock to buy?
Is Fulgent Genetics a public company?
Who is the CEO of Fulgent Genetics?
What are the analyst ratings for FLGT?
Investors · Request Kits · Billing · Forms · Login · 00. Investor Relations. Overview · News & Events · Press Releases · Events · Presentations · SEC Filings ...
Investor Relations. Overview · News & Events · Press Releases · Events ... Fulgent Investor Presentation 1.9 MB. Q4 2022 Fulgent Genetics Earnings Conference Call.
Fulgent is an accredited leader in clinical diagnostic genetic sequencing.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
On November 9, 2021, the Company updated its investor presentation, which is available on the “Investor Relations” section of the Company's website at https:// ...
According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.58. The reported EPS for the same ...